Altacor Strengthens Commercial Capability

European pharmaceutical company Norgine is to promote Cambridge-based Altacor’s Dry Eye product Clinitas® in the UK through its primary care sales teams.

Clinitas is a preservative free eyedrop for moderate Dry Eye that is prescribed by hospital-based ophthalmologists and primary care professionals and the agreement will help to raise product awareness in the part of medical community that is responsible for the continuity of patient care via follow-on prescribing from hospital recommendation. 

Peter Stein, Chairman of Norgine said: “We are pleased to initiate this collaboration with Altacor as a first step in what may become a broader partnering.”

Dr Fran Crawford, CEO of Altacor added, “We are particularly excited to be working with Norgine in such a creative approach to sales and marketing of specialty ophthalmology products. This deal will help grow sales of our Clinitas products for Dry Eye and provides us with a much stronger overall commercial platform in the UK. Our relationship with Norgine is important and we hope it will allow Altacor to identify further strategic opportunities to leverage Norgine’s pan-European commercial infrastructure and establish Altacor as a leading European specialty ophthalmology company.”